# WILLINGMED

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/willingmed

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.willingmed.com
- Total disclosed funding: $15M
- Latest round: Series B (Apr 3, 2023)
- Investors on record: 4

## About

Established in 2019 and based in Beijing, China, WILLINGMED is a medical service provider that focuses on an accurate diagnosis of infection. Dr. Yan Zhang, the founder, and CEO of the company, served as the dean of the Institute of Translational Medicine at Boao Biology and served as the technical research and development director of the scientific research management center at Boao Jingdian. The core team has nearly 20 years of experience in the precision testing of pathogenic microorganisms. It has more than 40 intellectual property rights as of 2023. In April 2023, Willingmed raised USD 14.53 million in series B funding from Galaxy Capital Management, Haier Capital, and Hunan Hi-Tech Venture Capital Health $ Elderly Care Fund Management Co., Ltd.

The company engages in the development of the accurate diagnosis of infection. Its main products include Plseq (Pathogen Identification Sequencing) metagenomic testing and WYSP high-throughput automation workstation. WYSP high-throughput automation workstation provides full-process intelligent automation services from sample preparation, library construction, and on-machine sequencing to clinical report generation.

The company intends to use the April 2023 funding to support the construction of a pathogenic microbial skynet laboratory.

## Funding rounds

- Series B, Apr 3, 2023, $15M — Galaxy Capital Management, Haier Capital, Hunan Hi-Tech Venture Capital Health $ Elderly Care Fund Management Co.,Ltd.
- Angel, Dec 17, 2019 — MED-FINE Capital

## Investors

- MED-FINE Capital (https://capitalatlas.ai/funds/med-fine-capital) — Angel
- Galaxy Capital Management (https://capitalatlas.ai/funds/galaxy-capital-management) — Series B
- Haier Capital (https://capitalatlas.ai/funds/haier-capital) — Series B
- Hunan Hi-Tech Venture Capital Health $ Elderly Care Fund Management Co.,Ltd. — Series B